Cargando…

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer

BACKGROUND: Radical treatment for oligometastatic non-small-cell lung cancer (NSCLC) has a curative potential for selected patients. The present retrospective study was designed to examine the relevance of synchronous vs. metachronous manifestations as a potential prognostic factor when ablative tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleckenstein, Jochen, Petroff, Alev, Schäfers, Hans-Joachim, Wehler, Thomas, Schöpe, Jakob, Rübe, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890277/ https://www.ncbi.nlm.nih.gov/pubmed/27255302 http://dx.doi.org/10.1186/s12885-016-2379-x

Ejemplares similares

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
por: Jones, Gregory D., et al.
Publicado: (2021)

Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET
por: Sabbagh, Ali, et al.
Publicado: (2022)

Efficacy and Safety of Local Radiotherapy to All Oligometastatic Sites in Elderly Patients with Metachronous Oligometastatic Cancers After Initial Treatment for the Primary Tumor
por: Hu, Xiaolong, et al.
Publicado: (2021)

Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
por: Mekenkamp, L J M, et al.
Publicado: (2010)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
por: Fleckenstein, Jochen, et al.
Publicado: (2015)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor
por: Pedrazzoli, Sergio
Publicado: (2023)

Isolated Splenic Metastasis of Primary Lung Cancer Presented as Metachronous Oligometastatic Disease—A Case Report
por: Reljic, Milorad, et al.
Publicado: (2022)

The Distinction of Clinicopathological Characteristics, Treatment Strategy and Outcome in Colorectal Cancer Patients With Synchronous vs. Metachronous Bone Metastasis
por: Ma, Chen-xi, et al.
Publicado: (2020)

Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand
por: Tangjitgamol, Siriwan, et al.
Publicado: (2015)

Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study
por: Chen, Ya, et al.
Publicado: (2022)

Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer
por: Huynh, Linda My, et al.
Publicado: (2022)

Isolated metachronous splenic metastasis from synchronous colon cancer
por: Gencosmanoglu, Rasim, et al.
Publicado: (2006)

Multicentric Giant Cell Tumor of Bone: Synchronous and Metachronous Presentation
por: Wirbel, Reiner, et al.
Publicado: (2013)

Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives
por: Almeldin, Doaa Said, et al.
Publicado: (2020)

Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy
por: Lorat, Yvonne, et al.
Publicado: (2020)

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer
por: Quéré, Gilles, et al.
Publicado: (2016)

Impact of Time to Metastasis (Synchronous vs. Metachronous) on Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with First Line Immune-Checkpoint Inhibitors (ICI)-based Combinations
por: Meza, Luis, et al.
Publicado: (2023)

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy
por: Bai, Hao, et al.
Publicado: (2016)

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy
por: Miyawaki, Taichi, et al.
Publicado: (2020)

Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum
por: Nash, GF, et al.
Publicado: (2012)

Metachronous or synchronous male breast and prostate cancers a duality to lookout for.
por: Mukendi, Alain Mwamba, et al.
Publicado: (2019)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer
por: Shibukawa, Narihiro, et al.
Publicado: (2017)

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors
por: Lv, Meng, et al.
Publicado: (2017)

Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages
por: Menga, Alessio, et al.
Publicado: (2020)

Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation
por: Serio, Gabriella, et al.
Publicado: (2022)

Synchronous/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors
por: Pan, Szu-Ying, et al.
Publicado: (2022)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2023)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

A rare case of metachronous neuroendocrine tumor after a colorectal adenocarcinoma: qualitative critical review of synchronous and metachronous gastrointestinal NET
por: Lancellotti, Francesco, et al.
Publicado: (2020)

Synchronous Oligometastatic Non-Small Cell Lung Cancer and Isolated Renal Cell Carcinoma: A Case Report and Literature Review
por: Nguyen, Timothy K, et al.
Publicado: (2015)

Renal Cell Carcinoma with Synchronous Metastasis to the Calcaneus and Metachronous Metastases to the Ovary and Gallbladder
por: Decoene, Jasper, et al.
Publicado: (2011)

Clinicopathological characteristics of synchronous and metachronous gastric neoplasms after endoscopic submucosal dissection
por: Jang, Mi Young, et al.
Publicado: (2013)

Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
por: Lee, Janghee, et al.
Publicado: (2015)

Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
por: Suh, Byoung Jo
Publicado: (2016)

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018)

Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases
por: Sapalidis, Konstantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_95rfq5qg1qu828iflgaj97hc9g